Exact Mass: 466.0851

Exact Mass Matches: 466.0851

Found 20 metabolites which its exact mass value is equals to given mass value 466.0851, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

BL IV

3,4-Bis(acetyloxy)-11,12-dihydroxy-5-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2,4,6,10,12-hexaen-6-yl acetic acid

C24H18O10 (466.09)


BL IV is found in mushrooms. BL IV is a constituent of the kurukawa mushroom (Boletopsis leucomelas) (edibility not reported)

   

(4-Chlorophenyl) (1R)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate

6-Chloro-1,3,4,9-tetrahydro-1-(4-methoxyphenyl)-, 4-chlorophenyl ester, (1S)-2H-pyrido(3,4-b)indole-2-carboxylic acid

C25H20Cl2N2O3 (466.0851)


   

EP_M467

EP_M467

C20H20ClFN4O4S (466.0878)


CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2204

   
   

Deacetylkirschsteinin

Deacetylkirschsteinin

C24H18O10 (466.09)


   

eriocephaloside

eriocephaloside

C24H18O10 (466.09)


   
   
   

5-(2-Bromophenyl)-1-trityl-1H-tetrazole

5-(2-Bromophenyl)-1-trityl-1H-tetrazole

C26H19BrN4 (466.0793)


   

(4-Chlorophenyl) 6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate

(4-Chlorophenyl) 6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate

C25H20Cl2N2O3 (466.0851)


C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor

   
   

S-[(1R,2R)-1-(2-chlorophenyl)-2-(4-fluorophenyl)-1,3-dihydroxy-3-(1H-1,2,4-triazol-1-yl)propan-2-yl]-L-cysteine

S-[(1R,2R)-1-(2-chlorophenyl)-2-(4-fluorophenyl)-1,3-dihydroxy-3-(1H-1,2,4-triazol-1-yl)propan-2-yl]-L-cysteine

C20H20ClFN4O4S (466.0878)


   

2-hydroxybenzoyl-AMP(1-)

2-hydroxybenzoyl-AMP(1-)

C17H17N5O9P- (466.0764)


   

4-hydroxybenzoyl-AMP(1-)

4-hydroxybenzoyl-AMP(1-)

C17H17N5O9P- (466.0764)


   

4-(Difluoromethoxy)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

4-(Difluoromethoxy)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C24H16F2N2O4S (466.0799)


   

N-[[5-(1H-benzimidazol-2-yl)-2-chloroanilino]-sulfanylidenemethyl]-2,6-dimethoxybenzamide

N-[[5-(1H-benzimidazol-2-yl)-2-chloroanilino]-sulfanylidenemethyl]-2,6-dimethoxybenzamide

C23H19ClN4O3S (466.0866)


   

3-hydroxybenzoyl-AMP

3-hydroxybenzoyl-AMP

C17H17N5O9P- (466.0764)


   

3-(acetyloxy)-5-[4-(acetyloxy)phenyl]-6,11,12-trihydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl acetate

3-(acetyloxy)-5-[4-(acetyloxy)phenyl]-6,11,12-trihydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl acetate

C24H18O10 (466.09)


   

17-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁴,¹⁹]henicosa-1(13),2(11),3(8),6,9,14(19),15,17-octaene-5,21-dione

17-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁴,¹⁹]henicosa-1(13),2(11),3(8),6,9,14(19),15,17-octaene-5,21-dione

C24H18O10 (466.09)


   

17-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-4,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁴,¹⁹]henicosa-1(13),2(11),3(8),6,9,14(19),15,17-octaene-5,21-dione

17-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-4,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁴,¹⁹]henicosa-1(13),2(11),3(8),6,9,14(19),15,17-octaene-5,21-dione

C24H18O10 (466.09)